Follow
Roberto Castelli
Title
Cited by
Cited by
Year
Rheumatoid factors: clinical applications
F Ingegnoli, R Castelli, R Gualtierotti
Disease markers 35, 727-734, 2013
3672013
Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients
M Cicardi, R Castelli, LC Zingale, A Agostoni
Journal of allergy and clinical immunology 99 (2), 194-196, 1997
2091997
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update
J Bohlius, K Bohlke, R Castelli, B Djulbegovic, MB Lustberg, M Martino, ...
Blood advances 3 (8), 1197-1210, 2019
2002019
Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management
LC Zingale, R Castelli, A Zanichelli, M Cicardi
Immunology and Allergy Clinics 26 (4), 669-690, 2006
1592006
Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation
M Cugno, R Castelli, M Cicardi
Autoimmunity reviews 8 (2), 156-159, 2008
1262008
The heparins and cancer: review of clinical trials and biological properties
R Castelli, F Porro, P Tarsia
Vascular medicine 9 (3), 205-213, 2004
1212004
Syncope in patients with pulmonary embolism: comparison between patients with syncope as the presenting symptom of pulmonary embolism and patients with pulmonary embolism …
R Castelli, P Tarsia, C Tantardini, G Pantaleo, AGF Porro
Vascular medicine 8 (4), 257-261, 2003
1002003
Lymphoproliferative disease and acquired C1 inhibitor deficiency
R Castelli, DL Deliliers, LC Zingale, EM Pogliani, M Cicardi
Haematologica 92 (5), 716-718, 2007
962007
Thrombosis and hemostatic abnormalities in hematological malignancies
R Colombo, P Gallipoli, R Castelli
Clinical Lymphoma Myeloma and Leukemia 14 (6), 441-450, 2014
862014
Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship
R Castelli, A Zanichelli, M Cicardi, M Cugno
Critical Reviews in Oncology/Hematology 87 (3), 323-332, 2013
752013
Reduction in transmission of hepatitis C after the introduction of a heat‐treatment step in the production of C1‐inhibitor concentrate
M Cicardi, PM Mannucci, R Castelli, MG Rumi, A Agostoni
Transfusion 35 (3), 209-212, 1995
641995
Thromboembolic complications in malignant haematological disorders
R Castelli, B Ferrari, A Cortelezzi, A Guariglia
Current Vascular Pharmacology 8 (4), 482-494, 2010
552010
Intrathoracic masses due to extramedullary hematopoiesis
R Castelli, G Graziadei, M Karimi, MD Cappellini
The American journal of the medical sciences 328 (5), 299-303, 2004
542004
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency
R Castelli, MA Wu, M Arquati, A Zanichelli, C Suffritti, D Rossi, M Cicardi
British Journal of Haematology 172 (6), 902-908, 2016
492016
The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity
MA Wu, R Castelli
Clinical Chemistry and Laboratory Medicine (CCLM) 54 (2), 207-214, 2016
472016
Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects
R Castelli, E Cassinerio, MD Cappellini, F Porro, G Graziadei, F Fabris
Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current …, 2007
472007
Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia: case reports and literature review
A Meo, E Cassinerio, R Castelli, D Bignamini, L Perego, MD Cappellini
International Journal of Laboratory Hematology 30 (5), 425-431, 2008
372008
Current and emerging treatment options for patients with relapsed myeloma
R Castelli, R Gualtierotti, N Orofino, A Losurdo, S Gandolfi, M Cugno
Clinical Medicine Insights: Oncology 7, CMO. S8014, 2013
342013
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function
R Castelli, GL Deliliers, R Colombo, G Moreo, P Gallipoli, G Pantaleo
Annals of hematology 93, 1523-1529, 2014
332014
Immunomodulatory Drugs: New Options for the Treatment of Myelodysplastic Syndromes
R Castelli, R Cassin, A Cannavò, M Cugno
Clinical Lymphoma Myeloma and Leukemia 2013 (13), 1-7, 2013
332013
The system can't perform the operation now. Try again later.
Articles 1–20